In the United States, the incarcerated population is aging. About 15% of incarcerated adults, or approximately 175,000 people, are now 55 years or older. As the incarcerated population ages, cancer has become one of the greatest threats to their health. And despite the growing prevalence, cancer outcomes among those incarcerated are worse than for those with no history of incarceration. 

In a new study, Yale researchers investigated the quality of cancer care received by people diagnosed with cancer during and immediately after incarceration — and whether differences in access to care might explain some of the mortality gaps. They found that people who had a cancer diagnosed during a period of incarceration, or shortly after their release, were less likely to receive prompt, guideline-recommended cancer care.

The findings are published in the journal JAMA Network Open. 

New research from Michigan State University reveals that race/ethnicity and food insecurity are two key factors associated with peripheral neuropathy.

Mayo Clinic researchers have developed a pioneering method to mend damaged hearts without open-heart surgery, an advance that could one day transform the treatment of heart failure. 

A new study from researchers at the Johns Hopkins Bloomberg School of Public Health finds that common fungal species may be adapting to higher temperatures in warmer sites within cities compared to cooler sites in the same city.A new study from researchers at the Johns Hopkins Bloomberg School of Public Health finds that common fungal species may be adapting to higher temperatures in warmer sites within cities compared to cooler sites in the same city.

The International Society for Stem Cell Research (ISSCR) and the Stem Cell Network (SCN) are pleased to partner to lead a joint initiative and a global conversation on workforce development in regenerative medicine. Through this collaboration, the organizations will examine current challenges and opportunities in trainee career development, identify skills gaps and future needs, and discuss strategies to help the field build the talent required for continued discovery, innovation, and health impact.

A large-scale MIT screen of tuberculosis proteins revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.